Locations

Solna, Sweden · Stockholm, Sweden

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Other

founded in

2017

Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database. Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.

Something looks off?
Open jobs at Elypta
Powered by Getro